Ignite Creation Date:
2024-07-17 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06467617
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-06-13
Brief Title:
Adebrelimab Plus Chemo and Recaticimab Perioperative Treatment for Resectable NSCLC
Sponsor:
Beijing Chest Hospital Capital Medical University
Organization:
Beijing Chest Hospital Capital Medical University
Organization Data
Organization:
Beijing Chest Hospital Capital Medical University
Class:
OTHER
Study ID:
BJXK-2024-IIT-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Chest Hospital Capital Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Jinghui Wang
Responsible Party Title:
Director of Research Laboratory Beijing Chest Hospital
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Beijing Chest Hospital Capital Medical University
Old Name:
None
Old Organization:
None